, Tracking Stock Market Picks
Enter Symbol:
Alexza Pharmaceuticals, Inc. (ALXA) [hlAlert]

down 79.07 %

Alexza Pharmaceuticals, Inc. (ALXA) rated Buy by ROTH Capital

Posted on: Tuesday,  Dec 4, 2012  8:25 AM ET by Roth Capital

Roth Capital rated Buy Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) on 12/04/2012, when the stock price was $5.64. Since
then, Alexza Pharmaceuticals, Inc. has lost 79.08% as of 08/27/2015's recent price of $1.18.
If you would have followed this Roth Capital's recommendation on ALXA, you would have lost 79.07% of your investment in 996 days.

Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/4/2012 8:25 AM Buy
as of 12/31/2012
1 Week down  -0.80 %
1 Month down  -12.23 %
3 Months   
1 YTD down  -12.23 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy